英国生物银行中体重指数与2型糖尿病关联的同质性:孟德尔随机化研究
该研究采用多分层孟德尔随机化方法,在英国生物银行287,394名自报白人英国裔无关个体中分析BMI对糖尿病 odds 的影响。个体按BMI、糖尿病家族史和全基因组糖尿病多基因风险评分分层。结果显示,BMI每降低1 kg/m²,各风险分层中糖尿病 odds 的降低幅度相似,提示所有个体均可通过减重降低糖尿病风险。
要点
- BMI每降低1 kg/m²,非超重且无家族史者糖尿病 odds 降低1.37倍(95%CI 1.12-1.68)。
- 肥胖且有家族史者BMI每降低1 kg/m²,糖尿病 odds 降低1.21倍(95%CI 1.13-1.29)。
- 减重对糖尿病风险的降低在不同BMI、家族史和遗传风险分层中高度一致。
核心结论
- 在英国生物银行队列中,较低BMI与糖尿病风险降低在不同BMI、家族史和遗传风险分层中一致相关,提示所有个体均可通过减重显著降低糖尿病风险。
- 结果支持将减重干预广泛部署于各糖尿病风险水平的个体。
研究设计与样本
- 多分层孟德尔随机化研究,纳入英国生物银行287,394名自报白人英国裔无关个体,2006至2010年招募,年龄40至69岁。
- 个体按BMI、糖尿病家族史和全基因组糖尿病多基因风险评分分层,主要结局为每1 kg/m² BMI降低的糖尿病 odds 比。
主要发现
- 糖尿病患病率随BMI、糖尿病家族史和遗传风险升高而急剧增加。
- 非超重(BMI<25 kg/m²)且无糖尿病家族史个体中,BMI每降低1 kg/m²与糖尿病 odds 降低1.37倍相关(95%CI 1.12-1.68)。
- 肥胖(BMI≥30 kg/m²)且有家族史个体中,BMI每降低1 kg/m²与糖尿病 odds 降低1.21倍相关(95%CI 1.13-1.29)。
临床怎么用
- 减重干预可考虑用于所有糖尿病风险水平的个体,而不仅限于高风险或糖尿病前期人群。
局限性
- 所研究的改变BMI的DNA序列多态性代表个体终生累积倾向,可能错误估计晚年减重干预的风险改善潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lifestyle interventions to reduce body mass index (BMI) are critical public health strategies for type 2 diabetes prevention. While weight loss interventions have shown demonstrable benefit for high-risk and prediabetic individuals, we aimed to determine whether the same benefits apply to those at lower risk. METHODS AND FINDINGS: We performed a multi-stratum Mendelian randomization study of the effect size of BMI on diabetes odds in 287,394 unrelated individuals of self-reported white British ancestry in the UK Biobank, who were recruited from across the United Kingdom from 2006 to 2010 when they were between the ages of 40 and 69 years. Individuals were stratified on the following diabetes risk factors: BMI, diabetes family history, and genome-wide diabetes polygenic risk score. The main outcome measure was the odds ratio of diabetes per 1-kg/m2 BMI reduction, in the full cohort and in each stratum. Diabetes prevalence increased sharply with BMI, family history of diabetes, and genetic risk. Conversely, predicted risk reduction from weight loss was strikingly similar across BMI and genetic risk categories. Weight loss was predicted to substantially reduce diabetes odds even among lower-risk individuals: for instance, a 1-kg/m2 BMI reduction was associated with a 1.37-fold reduction (95% CI 1.12-1.68) in diabetes odds among non-overweight individuals (BMI < 25 kg/m2) without a family history of diabetes, similar to that in obese individuals (BMI ≥ 30 kg/m2) with a family history (1.21-fold reduction, 95% CI 1.13-1.29). A key limitation of this analysis is that the BMI-altering DNA sequence polymorphisms it studies represent cumulative predisposition over an individual's entire lifetime, and may consequently incorrectly estimate the risk modification potential of weight loss interventions later in life. CONCLUSIONS: In a population-scale cohort, lower BMI was consistently associated with reduced diabetes risk across BMI, family history, and genetic risk categories, suggesting all individuals can substantially reduce their diabetes risk through weight loss. Our results support the broad deployment of weight loss interventions to individuals at all levels of diabetes risk.
引用
- Wainberg M, Mahajan A, Kundaje A, et al. Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study. PLoS Med. 2019. PMID: 31821322. doi:10.1371/journal.pmed.1002982
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。